IL90833A0 - Immunogenic peptide - Google Patents

Immunogenic peptide

Info

Publication number
IL90833A0
IL90833A0 IL90833A IL9083389A IL90833A0 IL 90833 A0 IL90833 A0 IL 90833A0 IL 90833 A IL90833 A IL 90833A IL 9083389 A IL9083389 A IL 9083389A IL 90833 A0 IL90833 A0 IL 90833A0
Authority
IL
Israel
Prior art keywords
immunogenic peptide
immunogenic
peptide
Prior art date
Application number
IL90833A
Other languages
English (en)
Original Assignee
Childrens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hospital Inc filed Critical Childrens Hospital Inc
Publication of IL90833A0 publication Critical patent/IL90833A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/088—Varicella-zoster virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/089—Cytomegalovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL90833A 1988-07-01 1989-06-30 Immunogenic peptide IL90833A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21430288A 1988-07-01 1988-07-01

Publications (1)

Publication Number Publication Date
IL90833A0 true IL90833A0 (en) 1990-01-18

Family

ID=22798566

Family Applications (1)

Application Number Title Priority Date Filing Date
IL90833A IL90833A0 (en) 1988-07-01 1989-06-30 Immunogenic peptide

Country Status (5)

Country Link
EP (1) EP0429470A1 (xx)
JP (1) JPH03505457A (xx)
AU (1) AU3849989A (xx)
IL (1) IL90833A0 (xx)
WO (1) WO1990000062A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124440A (en) * 1986-11-24 1992-06-23 The Childrens Hospital, Inc. Antibody and T cell recognition sites on glycoproteins comprising the GCI complex of human cytomegalovirus
WO1991004277A1 (en) * 1989-09-14 1991-04-04 Children's Biomedical Research Institute Monoclonal antibodies specific to cytomegalovirus glycoprotein
WO1994023744A1 (en) * 1993-04-16 1994-10-27 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
EP0914441A2 (en) 1996-04-23 1999-05-12 The Wistar Institute Of Anatomy And Biology Novel human cytomegalovirus dna constructs and uses therefor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689225A (en) * 1984-11-02 1987-08-25 Institut Merieux Vaccine for cytomegalovirus
DE3619720A1 (de) * 1986-06-12 1987-12-17 Behringwerke Ag Hauptglykoprotein des menschlichen cytomegalovirus, seine herstellung und verwendung
US5126130A (en) * 1986-11-24 1992-06-30 The Childrens Hospital Incorporated Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a

Also Published As

Publication number Publication date
JPH03505457A (ja) 1991-11-28
EP0429470A1 (en) 1991-06-05
AU3849989A (en) 1990-01-23
WO1990000062A1 (en) 1990-01-11

Similar Documents

Publication Publication Date Title
GB8927255D0 (en) Peptide derivatives
GB8907652D0 (en) Peptide derivatives
EP0355247A3 (en) Compressed-molded preparations
EP0391997A4 (en) Vaccine
ZA895137B (en) Novel peptides
ZA892269B (en) Peptides
GB8821077D0 (en) Peptides
IL90833A0 (en) Immunogenic peptide
ZA899167B (en) Peptides
AU3048689A (en) Immunogenic peptides
GB8828098D0 (en) Peptides
ZA896372B (en) Vaccine
ZA873796B (en) Peptides
GB8826452D0 (en) Peptide derivatives
GB8907902D0 (en) Peptide derivatives
IE882173L (en) Peptides
IE881990L (en) Peptides
IE880939L (en) Peptides
IE882649L (en) Peptides
GB8821076D0 (en) Peptides
IE881982L (en) Peptides
GB8804687D0 (en) Peptides
IE881270L (en) Peptides
IE882054L (en) Vaccine
GB8805603D0 (en) Vaccine